Market Overview:
The global lentiviral vectors market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for gene therapy and growing investment in R&D by pharmaceutical companies. Based on type, the global lentiviral vectors market is segmented into 1st-generation, 2nd-generation and 3rd-generation vectors. The 1st-generation vector segment dominates the global lentiviral vectors market and is expected to continue its dominance during the forecast period. This can be attributed to their high efficiency and easy production process as compared to other types of Lentiviral Vectors. Based on application, the hospital segment dominates the global lentiviral vectors market followed by clinic, research institution and others segments respectively. North America dominates the global LentiVector Market with a share of XX% in 2017 followed by Europe with a share of XX%.
Product Definition:
Lentiviral vectors are a type of virus that can transfer genetic material into cells. Lentiviral vectors have been used to deliver genes into muscle cells, neurons, and other types of cells. This technology has been used to study the function of genes and to develop new therapies for diseases such as cancer, AIDS, and heart disease.
1st-generation:
1st generation is the first set of viruses to be used in gene therapy. It was developed by French physician and scientist Robert Gallo for the treatment of cancerous cells. The virus can carry genes into human cells, which then integrate themselves into the cell’s genetic material and produce new proteins from their own nucleic acids (DNA or RNA). These new proteins are often more effective than those produced by the original tissue.
2nd-generation:
2nd generation is also known as Generation II. It is a group of lentiviral vectors developed by the insertion of an envelope gene from HIV-1 into the SARS-CoV-2 genome. The 2nd generation has several advantages over 1st generation such as it can infect both T cells and B cells, has higher transgene expression levels, and shows improved immune stimulation in vitro & in vivo activities.
Application Insights:
The hospital application segment led the market in 2017 and is projected to expand at a revenue-based CAGR of XX% over the forecast period. Lentiviral vectors are widely used for gene therapy, cell therapy, and vaccine production owing to their ability to transfect cells and introduce foreign genes into them with high efficiency. The growing adoption of these vectors for clinical applications such as stem cell therapies is expected to drive demand over the coming years.
Clinical trials are an important part of drug development process in any industry; this includes biopharmaceutical companies, academic institutions/research institutes, and government agencies. Clinical research involves several processes including planning & designing studies & experiments, gathering data from patients or participants involved in clinical trials through various methods such as interviews or questionnaires etc., analyzing data collected from patients or participants involved in clinical trials through various methods such as interviews or questionnaires etc.
Regional Analysis:
North America dominated the market in 2017 owing to a rise in R&D investments by public and private entities. Moreover, high prevalence of chronic diseases such as HIV/AIDS has led to an increase in demand for Lentiviral Vectors Therapy (LVT) which is further expected to drive the regional market over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to factors such as rising disposable income, improving healthcare infrastructure and growing target population base. Furthermore, increasing government initiatives towards development of novel therapies are projecteded boost regional growth over next eight years. For instance, National Health & Nutrition Examination Survey (NHANES) survey conducted from 2007-2010 showed that approximately 0.5% of children were born with HIV; this number was increasedto 1% among black children living with mothers who were infected during pregnancy or shortly after birth [1].
Growth Factors:
- Increasing demand for gene therapy and regenerative medicine
- Rising prevalence of chronic diseases such as cancer, HIV/AIDS, and heart diseases
- Growing number of collaborations and partnerships between biotechnology companies and research institutes for development of novel lentiviral vectors
- Technological advancements in the field of lentiviral vectors production
- Increasing investment by private equity firms in the biotech sector
Scope Of The Report
Report Attributes
Report Details
Report Title
Lentiviral Vectors Market Research Report
By Type
1st-generation, 2nd-generation, 3rd-generation
By Application
Hospital, Clinic, Research Institution, Others
By Companies
Thermo Fisher Scientific Sirion-Biotech GmbH, Vigene Biosciences, OriGene Technologies, SignaGen Laboratories, Sino Biological, Takara Bio, Cell Biolabs, GenTarget, GENEMEDI, Bluebird Bio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Lentiviral Vectors Market Report Segments:
The global Lentiviral Vectors market is segmented on the basis of:
Types
1st-generation, 2nd-generation, 3rd-generation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Research Institution, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific Sirion-Biotech GmbH
- Vigene Biosciences
- OriGene Technologies
- SignaGen Laboratories
- Sino Biological
- Takara Bio
- Cell Biolabs
- GenTarget
- GENEMEDI
- Bluebird Bio
Highlights of The Lentiviral Vectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1st-generation
- 2nd-generation
- 3rd-generation
- By Application:
- Hospital
- Clinic
- Research Institution
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lentiviral Vectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lentiviral vectors are a type of virus that can be used to deliver genes or other treatments into cells. Lentiviral vectors are small, circular pieces of DNA that can travel through the bloodstream and enter cells. Once inside the cell, the lentivirus can release its cargo, which could include genes or other treatments.
Some of the key players operating in the lentiviral vectors market are Thermo Fisher Scientific Sirion-Biotech GmbH, Vigene Biosciences, OriGene Technologies, SignaGen Laboratories, Sino Biological, Takara Bio, Cell Biolabs, GenTarget, GENEMEDI, Bluebird Bio.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lentiviral Vectors Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Lentiviral Vectors Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Lentiviral Vectors Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Lentiviral Vectors Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Lentiviral Vectors Market Size & Forecast, 2020-2028 4.5.1 Lentiviral Vectors Market Size and Y-o-Y Growth 4.5.2 Lentiviral Vectors Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1st-generation
5.2.2 2nd-generation
5.2.3 3rd-generation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Research Institution
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lentiviral Vectors Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lentiviral Vectors Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1st-generation
9.6.2 2nd-generation
9.6.3 3rd-generation
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Research Institution
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1st-generation
10.6.2 2nd-generation
10.6.3 3rd-generation
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Research Institution
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1st-generation
11.6.2 2nd-generation
11.6.3 3rd-generation
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Research Institution
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1st-generation
12.6.2 2nd-generation
12.6.3 3rd-generation
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Research Institution
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1st-generation
13.6.2 2nd-generation
13.6.3 3rd-generation
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Research Institution
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lentiviral Vectors Market: Competitive Dashboard
14.2 Global Lentiviral Vectors Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific Sirion-Biotech GmbH
14.3.2 Vigene Biosciences
14.3.3 OriGene Technologies
14.3.4 SignaGen Laboratories
14.3.5 Sino Biological
14.3.6 Takara Bio
14.3.7 Cell Biolabs
14.3.8 GenTarget
14.3.9 GENEMEDI
14.3.10 Bluebird Bio